CIOMS Guidance for Medicines Safety

Professor Hervé Le Louet,
President,CIOMS, Geneva, Switzerland

Professor Lembit Rago
Secretary General,CIOMS, Geneva, Switzerland

Quo vadis CIOMS?
Dr Lembit Rägo
Secretary General, CIOMS, Geneva, Switzerland

Patient Involvement in Drug Development and Safe Use
Mr François Houÿez
Director of Treatment Informtion and Access, European Organisation for Rare Diseases, France

Sever Cutaneous Adverse Reactions (SCARS)
Professor Hervé Le Louet
President, CIOMS, Geneva, Switzerland

Drug Induced Liver Injury (DILI)
Professor Raul Andrade
Secretary General, CIOMS, Geneva, Switzerland

Benefit/ Risk Assessment During the life-cycle of Medicines
TBC
TBC